Abeona Therapeutics (ABEO) Shares Outstanding (2010 - 2026)

Abeona Therapeutics' Shares Outstanding history runs 17 years deep, the most recent figure standing at $56.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 16.16% year-over-year to $56.9 million; the TTM figure through Mar 2026 stood at $56.9 million (up 16.16% YoY), while the FY2025 annual figure was $55.0 million, up 20.59% from the prior year.
• Shares Outstanding was $56.9 million for Q1 2026 at Abeona Therapeutics, up from $55.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $56.9 million in Q1 2026 to a low of $5.9 million in Q2 2022.
• Historically, Shares Outstanding has averaged $32.4 million across 5 years, with a median of $27.6 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding soared 265.87% in 2023, then climbed 16.16% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $17.7 million in 2022, then soared by 49.69% to $26.5 million in 2023, then surged by 72.09% to $45.6 million in 2024, then gained by 20.59% to $55.0 million in 2025, then advanced by 3.31% to $56.9 million in 2026.
• The last three Shares Outstanding figures came in at $56.9 million (Q1 2026), $55.0 million (Q4 2025), and $52.4 million (Q3 2025), per Business Quant data.